창상관리용 생물제제 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 제품별, 창상 유형별, 최종사용자별, 지역별, 경쟁별 세분화(2020-2030년)

The Global Wound Care Biologics Market, valued at USD 2.17 Billion in 2024, is projected to experience a CAGR of 6.19% to reach USD 3.11 Billion by 2030. Wound care biologics are advanced therapeutic products derived from living organisms or their components, engineered to augment the body's intrinsic healing mechanisms, facilitating tissue regeneration and repair for various wounds and tissue injuries. Key drivers supporting this market include the increasing global prevalence of chronic wounds, particularly those associated with an aging population and conditions such as diabetes.

Key Market Drivers

The increasing global incidence of chronic and acute wounds represents a fundamental demand driver for the Global Wound Care Biologics Market. Conditions such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers often require advanced interventions due to their complex pathology and delayed healing. The prevalence of these challenging wounds creates a substantial patient population seeking effective therapeutic solutions.

Key Market Challenges

A significant challenge impeding the growth of the Global Wound Care Biologics Market is the elevated cost associated with these advanced biological therapies. The substantial expenses inherent in their research, development, and complex manufacturing processes directly translate into high product pricing. This elevated cost restricts patient access, especially in healthcare systems with stringent budget limitations or where individual out-of-pocket expenses become prohibitive. Furthermore, it introduces considerable complexities in obtaining favorable reimbursement from payers, as these entities often require extensive evidence of superior cost-effectiveness compared to existing, less expensive treatments.

Key Market Trends

The emergence of personalized wound care biologics solutions represents a pivotal market trend, moving away from uniform treatments to therapies tailored to individual patient needs and specific wound characteristics. This involves employing advanced diagnostics, such as biomarker analysis and genomic profiling, to predict therapeutic responses and guide the selection of the most effective biologic agents. This tailored approach aims to enhance treatment efficacy, reduce healing times, and optimize healthcare resource allocation by ensuring appropriate therapy application.

Key Market Players

• Smith & Nephew Plc
• Integra LifeSciences Corporation
• Wright Medical Group N.V.
• MiMedx Group, Inc.
• Vericel Corporation
• Osiris Therapeutics, Inc.
• Organogenesis Holdings Inc.
• Solsys Medical, LLC
• Lavior Pharma Inc.
• Marine Polymer Technologies, Inc.

Report Scope:

In this report, the Global Wound Care Biologics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Wound Care Biologics Market, By Product:

• Biologic Skin Substitutes
• Topical Agents

Wound Care Biologics Market, By Wound Type:

• Ulcers
• Surgical and Traumatic Wounds
• Burns

Wound Care Biologics Market, By End User:

• Hospitals
• ASCs
• Burn Centers
• Wound Clinics

Wound Care Biologics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Wound Care Biologics Market.

Available Customizations:

Global Wound Care Biologics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Wound Care Biologics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Biologic Skin Substitutes, Topical Agents)
  • 5.2.2. By Wound Type (Ulcers, Surgical and Traumatic Wounds, Burns)
  • 5.2.3. By End User (Hospitals, ASCs, Burn Centers, Wound Clinics)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Wound Care Biologics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Wound Type
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Wound Care Biologics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Wound Type
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Wound Care Biologics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Wound Type
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Wound Care Biologics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Wound Type
      • 6.3.3.2.3. By End User

7. Europe Wound Care Biologics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Wound Type
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Wound Care Biologics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Wound Type
      • 7.3.1.2.3. By End User
  • 7.3.2. France Wound Care Biologics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Wound Type
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Wound Care Biologics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Wound Type
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Wound Care Biologics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Wound Type
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Wound Care Biologics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Wound Type
      • 7.3.5.2.3. By End User

8. Asia Pacific Wound Care Biologics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Wound Type
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Wound Care Biologics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Wound Type
      • 8.3.1.2.3. By End User
  • 8.3.2. India Wound Care Biologics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Wound Type
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Wound Care Biologics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Wound Type
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Wound Care Biologics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Wound Type
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Wound Care Biologics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Wound Type
      • 8.3.5.2.3. By End User

9. Middle East & Africa Wound Care Biologics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Wound Type
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Wound Care Biologics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Wound Type
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Wound Care Biologics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Wound Type
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Wound Care Biologics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Wound Type
      • 9.3.3.2.3. By End User

10. South America Wound Care Biologics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Wound Type
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Wound Care Biologics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Wound Type
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Wound Care Biologics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Wound Type
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Wound Care Biologics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Wound Type
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Wound Care Biologics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Smith & Nephew Plc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Integra LifeSciences Corporation
• 15.3. Wright Medical Group N.V.
• 15.4. MiMedx Group, Inc.
• 15.5. Vericel Corporation
• 15.6. Osiris Therapeutics, Inc.
• 15.7. Organogenesis Holdings Inc.
• 15.8. Solsys Medical, LLC
• 15.9. Lavior Pharma Inc.
• 15.10. Marine Polymer Technologies, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer